系统性硬化症相关的间歇性肺病:2024年如何管理?
Rocio Bautista-Sanchez1, Dinesh Khanna2
1Division of Rheumatology, University of Michigan, Ann Arbor, MI, Michigan USA.
系统性硬化症相关的间歇性肺病 (SSc-ILD) 影响许多患者,是导致死亡的主要原因. 本综述指导了管理,重点是免疫抑制剂,如甲酸莫菲蒂尔,托西利祖马布和利图西马布.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 系统性硬化症 (SSc) 是一种导致纤维化的自身免疫性疾病.
- 间歇性肺病 (ILD) 在65%的患者中复杂化SSc,导致40%的SSc死亡.
- 对SSc-ILD的危险因素包括男性性别,非洲遗产,高mRSS,抗Scl-70和ANA核细胞模式.
研究的目的:
- 为管理SSc-ILD提供最新的指南.
- 审查目前和新兴的SSc-ILD治疗策略.
主要方法:
- 审查有关SSc-ILD诊断和管理的当前文献.
- 分析支持一线免疫抑制疗法的证据.
- 讨论抗纤维素药物和新型治疗方法,如CAR-T细胞疗法和干细胞移植.
主要成果:
- 高分辨率计算机断层扫描 (HRCT) 是SSc.ILD诊断的关键.
- 肺功能测试 (PFT) 和脱测试对于监测SSc-ILD至关重要.
- 推使用mycophenolate mofetil,tocilizumab和rituximab作为第一线免疫抑制治疗.
结论:
- 有效管理SSc-ILD需要一个多方面的方法.
- 免疫抑制疗法是当前SSc-ILD治疗的基石.
- 新型疗法为SSc-ILD管理提供了未来的希望.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Myocarditis IV: Nursing Management
